Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Erwin Syarifuddin

9PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Jun 25, 2026
Blood-Based vs. Tissue-Based mRNA Expression of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, and Methylenetetrahydrofolate Reductase: A Prospective Study to Predict the Neoadjuvant CAPEOX Response in Advanced Colorectal Cancer.

|Feb 09, 2026
Towards Precision Oncology: A Predictive Nomogram Incorporating DPD and MTHFR for CapeOX Neoadjuvant Chemotherapy in Colorectal Cancer.

Elvida Christy Imelda Tahiya, Ronald Erasio Lusikooy, Ilhamjaya Pattelongi

|Nov 28, 2025
Perioperative Thrombocytosis as a Predictor of Long-Term Survival in Colorectal Cancer Patients: A Retrospective Cohort Study.

Andi Tri Sutrisno, Erwin Syarifuddin, Samuel Sampetoding

|Oct 28, 2025
Advancing Non-Invasive Genomic Detection of p53 Tumor Suppressor Mutations in Fecal and Tumor Tissues of Colorectal Cancer Patients in Makassar.

Unggul Jatmiko, Warsinggih Warsinggih, A M Luthfi Parewangi

|Oct 28, 2025
Validation of Platelet-index based Score (PIBS) for Early Prediction of the Pathological Stage in Colorectal Cancer.

Adi Madethen, Ronald Erasio Lusikooy, Julianus Aboyaman Uwuratuw

|Aug 24, 2025
The Ideal Second-Line Treatment Options for Patients with Advanced Biliary Tract Cancer Refractory to Gemcitabine-Based First-Line Chemotherapy: A Result From Bayesian Network-Meta Analysis.

Erwin Syarifuddin, Citra Aryanti

Pageof 2

Frequent Collaborators

6 joint publications

Citra Aryanti

6 joint publications

Samuel Sampetoding

6 joint publications

Warsinggih Warsinggih

6 joint publications

Julianus Aboyaman Uwuratuw

5 joint publications

Ronald Erasio Lusikooy

3 joint publications

Muhammad Ihwan Kusuma

2 joint publications

Unggul Jatmiko

2 joint publications

Rusdina Bte Ladju

2 joint publications

Rina Masadah

2 joint publications

Ibrahim Labeda

Frequent Collaborators

6 joint publications

Citra Aryanti

6 joint publications

Samuel Sampetoding

6 joint publications

Warsinggih Warsinggih

6 joint publications

Julianus Aboyaman Uwuratuw